Clinical studies to check the effectiveness of neutracitical Nanoparticles for its Bilirubin reduction properties
Phase 1
- Conditions
- Health Condition 1: Z673- Type AB blood
- Registration Number
- CTRI/2024/07/071406
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Prospective, ethical and compassionate trial for select cohort of neonates at most risk of exchange transfusion and need for escalated ? neonatal care for SNH to ascertain a long-term childhood reduction in known adverse outcomes.
Exclusion Criteria
Infants whose parents refused to provide informed consent
Infants with conjugated hyperbilirubinemia
Infants with other threatening congenital anomalies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method